Suppression of Extrapancreatic Glucagon by Octreotide May Reduce the Fasting and Postprandial Glucose Levels in a Diabetic Patient after Total Pancreatectomy

A 52-year-old woman was treated with sensor augmented pump therapy after undergoing total pancreatectomy for a nonfunctional pancreatic neuroendocrine tumor (NET). The secretion of both endogenous insulin and pancreatic glucagon were completely depleted. Octreotide long acting repeatable (Oct-LAR) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuma, Hideyuki, Bouchi, Ryotaro, Masuda, Seizaburo, Takeuchi, Takato, Murakami, Masanori, Minami, Isao, Izumiyama, Hajime, Hashimoto, Koshi, Yoshimoto, Takanobu, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725861/
https://www.ncbi.nlm.nih.gov/pubmed/28943578
http://dx.doi.org/10.2169/internalmedicine.8963-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725861/
https://www.ncbi.nlm.nih.gov/pubmed/28943578
http://dx.doi.org/10.2169/internalmedicine.8963-17

Ejemplares similares